<

NANOBIOTIX (EPA:NANO) Nanobiotix Announces Completion of Phase 1 Dose Escalation and NBTXR3 Recommended Phase 2 Dose for the Treatment of Inoperable, Recurrent Lung Cancer in Patients Amenable to Re-Irradiation

Transparency directive : regulatory news

02/04/2024 22:15



Other stories

12/04/2024 19:31
12/04/2024 23:10
12/04/2024 18:08
12/04/2024 20:19
13/04/2024 00:45
12/04/2024 18:18
12/04/2024 18:41
12/04/2024 20:32
12/04/2024 13:04
12/04/2024 21:40
12/04/2024 20:48
12/04/2024 23:11
12/04/2024 15:04
12/04/2024 14:47
12/04/2024 17:01
12/04/2024 20:17
12/04/2024 16:17
12/04/2024 13:00
11/04/2024 22:06
12/04/2024 17:57
12/04/2024 21:40
11/04/2024 18:07
12/04/2024 21:44
12/04/2024 20:53
12/04/2024 18:00
12/04/2024 16:55
12/04/2024 22:30
12/04/2024 18:05
12/04/2024 11:33
12/04/2024 21:14
11/04/2024 11:22
12/04/2024 18:00
11/04/2024 23:08
11/04/2024 18:28
12/04/2024 16:44
12/04/2024 21:58
12/04/2024 22:08
11/04/2024 07:00